Covid-19 live updates: FDA advisers to review vaccine for children ages 5 to 11
Published
The advisory committee is expected to vote by the end of the day on whether the benefits outweigh the risks of the shot.
Full ArticlePublished
The advisory committee is expected to vote by the end of the day on whether the benefits outweigh the risks of the shot.
Full ArticleWatch VideoThe Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19..
WASHINGTON (AP) — FDA advisers endorse Pfizer’s COVID-19 vaccine for children ages 5 to 11.